Minerva Neuroscience
Clinical development of treatments for central nervous system disorders.
Launch date
Employees
Market cap
AUD31.9m
Enterprise valuation
(AUD16m) (Public information from Sep 2024)
Share price
$2.817 NERV
Waltham Massachusetts (HQ)
Authorizing premium user...